Clinical and biological relevance of PML breakpoints in acute promyelocytic leukemia.

被引：0
|
作者：
Khoury, H
Nevill, TJ
Dalal, BI
Shepherd, JD
Hogge, DE
Toze, CL
Conneally, EA
Sutherland, HJ
Nantel, SH
Barnett, MJ
Le, A
Brockington, DA
Vickars, LM
Horsman, DE
机构：
[1] British Columbia Canc Agcy, Leukemia BMT Program, Div Hematol, Vancouver Gen Hosp, Vancouver, BC V5Z 4E6, Canada
[2] Vancouver Gen Hosp, Vancouver, BC, Canada
[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
454
引用
下载
收藏
页码：108A / 108A
页数：1
相关论文
共 50 条
  • [1] Targeted disruption of the PML gene of acute promyelocytic leukemia.
    Pandolfi, PP
    Rivi, R
    Gaboli, M
    Giorgio, M
    Antoniou, M
    Bygrave, A
    Fagioli, M
    CordonCardo, C
    Pelicci, PG
    Luzzatto, L
    Grosveld, F
    BLOOD, 1995, 86 (10) : 1031 - 1031
  • [2] CLINICAL RELEVANCE OF THE PML-RAR-A GENE REARRANGEMENT IN ACUTE PROMYELOCYTIC LEUKEMIA
    LOCOCO, F
    PELICCI, PG
    BIONDI, A
    LEUKEMIA & LYMPHOMA, 1994, 12 (5-6) : 327 - 332
  • [3] C/EBP is deregulated by PML-RAR in acute promyelocytic leukemia.
    Guibal, F
    Radomska, HS
    Johansen, LM
    Tenen, DG
    BLOOD, 2005, 106 (11) : 844A - 845A
  • [4] Acute promyelocytic leukemia. Clinical case report
    De Alba Iriarte, B.
    Redin Sarasola, M. E.
    Barado Hualde, J.
    Cabezon Vicente, R.
    Izquierdo Vicente, M. J.
    Pascual Usandizaga, P.
    Oliveros Conejero, R.
    Irurzun Moran, A. M.
    CLINICA CHIMICA ACTA, 2019, 493 : S200 - S201
  • [5] Sentrinization and ubiquitination differentially regulate the fate of PML and PML-RARα in acute promyelocytic leukemia.
    Kamitani, T
    Yeh, ETH
    BLOOD, 1998, 92 (10) : 404A - 404A
  • [6] MiRNA transcription is regulated by the PML-RARα oncoprotein in acute promyelocytic leukemia.
    Nigten, Jeannet
    Knops, Ruth
    Nikoloski, Gorica
    de Witte, Theo M.
    van der Reijden, Bert A.
    Jansen, Joop H.
    BLOOD, 2006, 108 (11) : 129B - 129B
  • [7] Clinical and biological relevance of immunophenotype in acute promyelocytic leukemia: A study of 196 cases
    Guglielmi, C
    Martelli, MP
    Diverio, D
    Fenu, S
    Vegna, ML
    Cantu-Rajinoldi, A
    Biondi, R
    Cocito, MG
    Del Vecchio, L
    Tabilio, A
    Avvisati, G
    Basso, G
    Lo Cocco, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 14 - 15
  • [8] Management of acute promyelocytic leukemia.
    Tallman M.S.
    Nabhan C.
    Current Oncology Reports, 2002, 4 (5) : 381 - 389
  • [9] Correlation of PML-RARa mRNA transcript type with morphology, cytogenetics and clinical parameters in acute promyelocytic leukemia.
    Viswanatha, D
    Kopecky, KJ
    Doss, K
    Rankin, C
    Head, DR
    Magenis, RE
    Appelbaum, FR
    Willman, CL
    LABORATORY INVESTIGATION, 1996, 74 (01) : 730 - 730
  • [10] CORRELATION OF CD2 EXPRESSION WITH PML GENE BREAKPOINTS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
    CLAXTON, DF
    READING, CL
    NAGARAJAN, L
    TSUJIMOTO, Y
    ANDERSSON, BS
    ESTEY, E
    CORK, A
    HUH, YO
    TRUJILLO, J
    DEISSEROTH, AB
    BLOOD, 1992, 80 (03) : 582 - 586
12345